PerkinElmer launches workstations for COVID-19 detection

By The Science Advisory Board staff writers

August 18, 2020 -- PerkinElmer has launched a series of new workstations for SARS-CoV-2 testing.

The company's new explorer workstations are modular, scalable, and capable of running up to 10,000 tests per day, according to the firm. They streamline SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) testing, which improves laboratory workflows, PerkinElmer said.

PerkinElmer launches free COVID-19 data dashboards
PerkinElmer has launched two free, open access COVID-19 data dashboards to speed up the discovery of antivirals and vaccines for the infection.
PerkinElmer Q1 revenues edge up, profit edges down
In financial results for the first quarter, PerkinElmer saw revenues grow slightly, but net income slipped.
PerkinElmer launches new workflow tools
PerkinElmer has released a variety of new tools to help pharmaceutical, semiconductor, biomonitoring, and food and material labs improve their testing...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter